Chin-Chou Huang Selected Research

Biomarkers (Surrogate Marker)

1/2022	Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
10/2020	Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.
6/2020	SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TYPE 1 LEVELS EXHIBIT THE BETTER ASSOCIATION WITH RENAL OUTCOMES THAN TRADITIONAL RISK FACTORS IN CHINESE SUBJECTS WITH TYPE 2 DIABETES MELLITUS.
11/2009	Glucose and non-glucose predictors of future onset of type 2 diabetes in newly diagnosed essential hypertensives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chin-Chou Huang Research Topics

Disease

14	Hypertension (High Blood Pressure) 01/2022 - 04/2011
11	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 06/2010
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2011
9	Heart Failure 01/2022 - 01/2016
8	Myocardial Infarction 01/2022 - 01/2012
7	Ischemic Stroke 01/2022 - 12/2012
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2009
5	Inflammation (Inflammations) 01/2022 - 05/2011
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2018
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 12/2011
5	Atrial Fibrillation 12/2020 - 03/2010
4	Stroke (Strokes) 10/2021 - 03/2013
3	Atherosclerosis 12/2022 - 07/2016
3	Diabetes Mellitus 03/2020 - 05/2011
3	Chronic Renal Insufficiency 01/2018 - 05/2011
3	Neoplasms (Cancer) 01/2013 - 04/2011
2	Albuminuria 01/2022 - 06/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2021 - 01/2012
2	Death (Near-Death Experience) 05/2020 - 01/2020
2	Hypercholesterolemia 03/2020 - 07/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2014 - 10/2013
2	Asthma (Bronchial Asthma) 09/2014 - 05/2011
2	Peptic Ulcer (Peptic Ulcers) 01/2013 - 12/2011
2	Hemorrhage 01/2013 - 12/2011
2	Non-alcoholic Fatty Liver Disease 01/2012 - 12/2010
1	Necrosis 01/2022
1	Hypertensive Nephropathy 01/2022
1	Arteriovenous Fistula 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	Masked Hypertension 01/2021
1	End Stage Liver Disease 11/2020
1	Macular Degeneration (Age-Related Maculopathy) 03/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020
1	Homozygous Familial Hypercholesterolemia 01/2019
1	Heart Arrest (Cardiac Arrest) 03/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Kidney Diseases (Kidney Disease) 04/2016
1	Isolated Systolic Hypertension 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Diastolic Heart Failure 01/2016

Drug/Important Bio-Agent (IBA)

7	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
5	LipidsIBA 12/2022 - 10/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2011
4	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 08/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
3	LDL CholesterolIBA 12/2022 - 01/2019
3	fibroblast growth factor 21IBA 01/2022 - 01/2016
3	ThiazidesIBA 01/2016 - 01/2013
3	Angiotensin Receptor AntagonistsIBA 08/2015 - 04/2011
2	BilirubinIBA 11/2020 - 07/2016
2	Type I Tumor Necrosis Factor ReceptorsIBA 10/2020 - 06/2020
2	Indicators and Reagents (Reagents)IBA 03/2020 - 12/2012
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016 - 01/2013
2	Insulin (Novolin)FDA Link 12/2014 - 04/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2014 - 09/2014
2	C-Reactive ProteinIBA 05/2013 - 12/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2013 - 01/2013
2	erucylphosphocholineIBA 01/2013 - 01/2012
2	Clopidogrel (Plavix)FDA Link 01/2013 - 06/2010
1	oxidized low density lipoproteinIBA 12/2022
1	NucleotidesIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	CytokinesIBA 01/2022
1	CholesterolIBA 01/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2022
1	PTX3 proteinIBA 01/2022
1	Lipocalin-2IBA 01/2022
1	Chitinase-3-Like Protein 1IBA 01/2022
1	Member 3 Solute Carrier Family 12IBA 01/2022
1	CalciumIBA 01/2022
1	Nifedipine (Adalat)FDA LinkGeneric 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	Phosphates (Orthophosphate)IBA 10/2021
1	AlbuminsIBA 11/2020
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	Ether (Diethyl Ether)IBA 06/2020
1	MelatoninIBA 03/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	OxylipinsIBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	evolocumabIBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	AntioxidantsIBA 07/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 04/2016
1	LigandsIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2013
6	Percutaneous Coronary Intervention 10/2021 - 06/2010
2	Renal Dialysis (Hemodialysis) 01/2022 - 12/2011
2	Catheter Ablation 02/2013 - 03/2010
1	Ambulatory Care (Outpatient Care) 01/2021
1	Peritoneal Dialysis 12/2020
1	Cardiopulmonary Resuscitation (CPR) 03/2017
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017
1	Aftercare (After-Treatment) 01/2016